Biosimilars and Cannabis In Workers’ Comp
The Division of Workers’ Compensation’s Pharmacy and Therapeutics committee members coalesced around a recommendation concerning how the Division should deal with the emerging group of biosimilar drugs coming onto the market. Coverage for cannabis was also considered, but they decided to follow the federal government’s lead. Biologics are medications produced through biotechnology from ingredients derived …